Burden of tuberculosis and TB/HIV co-infection in Dushanbe

The objective of the study: to determine the burden of tuberculosis with concurrent HIV infection in Dushanbe and the prevalence of multiple drug resistant tuberculosis, to assess the treatment efficacy of drug susceptible and drug resistant tuberculosis depending on the HIV status of patients.Subje...

Full description

Bibliographic Details
Main Authors: B. P. Pirmakhmadzoda, Z. Kh. Tilloeva, Kh. S. Sharifzoda, O. Ya. Kabirov, K. A. Imomnazarova, S. M. Odinaeva
Format: Article
Language:Russian
Published: New Terra Publishing House 2021-03-01
Series:Туберкулез и болезни лёгких
Subjects:
Online Access:https://www.tibl-journal.com/jour/article/view/1510
_version_ 1826563012350181376
author B. P. Pirmakhmadzoda
Z. Kh. Tilloeva
Kh. S. Sharifzoda
O. Ya. Kabirov
K. A. Imomnazarova
S. M. Odinaeva
author_facet B. P. Pirmakhmadzoda
Z. Kh. Tilloeva
Kh. S. Sharifzoda
O. Ya. Kabirov
K. A. Imomnazarova
S. M. Odinaeva
author_sort B. P. Pirmakhmadzoda
collection DOAJ
description The objective of the study: to determine the burden of tuberculosis with concurrent HIV infection in Dushanbe and the prevalence of multiple drug resistant tuberculosis, to assess the treatment efficacy of drug susceptible and drug resistant tuberculosis depending on the HIV status of patients.Subjects: A cohort retrospective study was carried out assessing results of examination and treatment of all patients (1,838 people) registered for tuberculosis treatment from 01.06.2016 to 25.12.2019 in Dushanbe.Results. Among new tuberculosis cases, MDR is more often registered in HIV positive patients versus HIV negative patients (OR 2.3, 95% CI 1.1-4.9, p = 0.03). The chances of successful treatment of tuberculosis in HIV negative patients were higher versus HIV positive patients as well as in drug susceptible tuberculosis (OR 4.7, 95% CI 3.1-7.4; p < 0.000) versus drug resistant tuberculosis (OR 2.5, 95% CI 1.1-75.7; p = 0.03). The chances of tuberculosis cure did not differ statistically significantly among patients with different HIV status for both drug resistant and drug susceptible tuberculosis.
first_indexed 2024-03-12T18:41:10Z
format Article
id doaj.art-cd6c2a64f6794696a68dc8e48c320f12
institution Directory Open Access Journal
issn 2075-1230
2542-1506
language Russian
last_indexed 2025-03-14T09:57:12Z
publishDate 2021-03-01
publisher New Terra Publishing House
record_format Article
series Туберкулез и болезни лёгких
spelling doaj.art-cd6c2a64f6794696a68dc8e48c320f122025-03-02T11:22:33ZrusNew Terra Publishing HouseТуберкулез и болезни лёгких2075-12302542-15062021-03-01992404410.21292/2075-1230-2021-99-2-40-441507Burden of tuberculosis and TB/HIV co-infection in DushanbeB. P. Pirmakhmadzoda0Z. Kh. Tilloeva1Kh. S. Sharifzoda2O. Ya. Kabirov3K. A. Imomnazarova4S. M. Odinaeva5City Center for Population Protection from TuberculosisCity Center for Population Protection from TuberculosisDushanbe City Health AdministrationNational Reference Laboratory, National Center of Tuberculosis, Lung Diseases and Thoracic SurgeryCity Center for Population Protection from TuberculosisCity Center for Population Protection from TuberculosisThe objective of the study: to determine the burden of tuberculosis with concurrent HIV infection in Dushanbe and the prevalence of multiple drug resistant tuberculosis, to assess the treatment efficacy of drug susceptible and drug resistant tuberculosis depending on the HIV status of patients.Subjects: A cohort retrospective study was carried out assessing results of examination and treatment of all patients (1,838 people) registered for tuberculosis treatment from 01.06.2016 to 25.12.2019 in Dushanbe.Results. Among new tuberculosis cases, MDR is more often registered in HIV positive patients versus HIV negative patients (OR 2.3, 95% CI 1.1-4.9, p = 0.03). The chances of successful treatment of tuberculosis in HIV negative patients were higher versus HIV positive patients as well as in drug susceptible tuberculosis (OR 4.7, 95% CI 3.1-7.4; p < 0.000) versus drug resistant tuberculosis (OR 2.5, 95% CI 1.1-75.7; p = 0.03). The chances of tuberculosis cure did not differ statistically significantly among patients with different HIV status for both drug resistant and drug susceptible tuberculosis.https://www.tibl-journal.com/jour/article/view/1510tuberculosisdrug susceptibility of mycobacterium tuberculosishiv statustreatment
spellingShingle B. P. Pirmakhmadzoda
Z. Kh. Tilloeva
Kh. S. Sharifzoda
O. Ya. Kabirov
K. A. Imomnazarova
S. M. Odinaeva
Burden of tuberculosis and TB/HIV co-infection in Dushanbe
Туберкулез и болезни лёгких
tuberculosis
drug susceptibility of mycobacterium tuberculosis
hiv status
treatment
title Burden of tuberculosis and TB/HIV co-infection in Dushanbe
title_full Burden of tuberculosis and TB/HIV co-infection in Dushanbe
title_fullStr Burden of tuberculosis and TB/HIV co-infection in Dushanbe
title_full_unstemmed Burden of tuberculosis and TB/HIV co-infection in Dushanbe
title_short Burden of tuberculosis and TB/HIV co-infection in Dushanbe
title_sort burden of tuberculosis and tb hiv co infection in dushanbe
topic tuberculosis
drug susceptibility of mycobacterium tuberculosis
hiv status
treatment
url https://www.tibl-journal.com/jour/article/view/1510
work_keys_str_mv AT bppirmakhmadzoda burdenoftuberculosisandtbhivcoinfectionindushanbe
AT zkhtilloeva burdenoftuberculosisandtbhivcoinfectionindushanbe
AT khssharifzoda burdenoftuberculosisandtbhivcoinfectionindushanbe
AT oyakabirov burdenoftuberculosisandtbhivcoinfectionindushanbe
AT kaimomnazarova burdenoftuberculosisandtbhivcoinfectionindushanbe
AT smodinaeva burdenoftuberculosisandtbhivcoinfectionindushanbe